Trademark Search in Canada

VULNERABILITY NETWORK

View On IC.GC.CA

SEARCHED

on 24 Jul 2024

Last Applicant/ Owned by

Zephyr AI, Inc.

3889 Maple Avenue,Suite 500Dallas TX 75219

Serial Number

2263841 filed on 7^th Dec 2022

Correspondent Address

CABINET JURIDIQUE ST. LAWRENCE S.E.N.C.R.L.

2301, Saint-Patrick Street,Suite B6Montreal

QUÉBEC

H3K1B3

VULNERABILITY NETWORK

Trademark usage description

providing scientific consultancy services in the field of healthcare, medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; analys Read More

Classification Information

Class [042]
Providing scientific consultancy services in the field of healthcare, medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; analysis of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data for scientific research purposes; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, biology, and pharmaceuticals; providing medical and scientific research information in the fields of genetics, oncology, biology, and pharmaceuticals; drug discovery services; healthcare, medical, and scientific services, namely, providing scientific information via databases in the fields of genetic, oncology, and biology for inputting, collecting, analyzing and managing data for treatment and diagnostic purposes; providing scientific, medical and clinical research and consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods; medical and scientific research and consulting, namely, designing and supporting clinical trials for others; research and development services in the creation of databases and collections of information and data on biologicals for research purposes; providing genetic reference databases being collections of gene sequences for research purposes; disease modeling for research purposes; services using machine-learning algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer and other diseases; biomarker rankings; research and development of pharmaceutical preparations and medicines; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of cancer treatment and diagnosis; genetic mapping for scientific purposes.

Classification kind code

Class [044]
Genetic mapping for medical purposes; healthcare and medical services, namely, analyzing genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies.

Classification kind code

Mark Details

Serial Number

2263841

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 7^th Apr 2025	Agent Changed
Submitted for opposition 22 on 24^th Jul 2024	Search Recorded
Submitted for opposition 20 on 24^th Jul 2024	Examiner's First Report
Submitted for opposition 223 on 24^th Jul 2024	Total Provisional Refusal
Submitted for opposition 256 on 15^th Apr 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 15^th Jun 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 14^th Jun 2023	Formalized
Submitted for opposition 1 on 14^th Jun 2023	Created
Submitted for opposition 228 on 7^th Dec 2022	International Registration
Submitted for opposition 30 on 7^th Dec 2022	Filed

VULNERABILITY NETWORK

Classification Information

Classification kind code

Class [044]Genetic mapping for medical purposes; healthcare and medical services, namely, analyzing genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [044]
Genetic mapping for medical purposes; healthcare and medical services, namely, analyzing genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies.